Wuxi Biologics (Cayman) Inc. - ADR

Wuxi Biologics (Cayman) Inc. - ADR

WXXWY

Get informed when a big investor buys or sells

+ Follow
Market Cap$28.64B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Wuxi Biologics (Cayman) Inc. - ADRWuxi Biologics (Cayman) Inc. - ADR38.5-19%0.70.1
$-0.13

Current Fair Value

100.9% downside

Overvalued by 100.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$28.64 Billion
Enterprise Value$25.95 Billion
Dividend Yield$- (-)
Earnings per Share$2.38
Beta0.6
Outstanding Shares2,048,323,612

Return

Return on Equity18.99%ROE
Return on Assets13.96%
Return on Invested Capital23.49%

Valuation & Multiples

P/E Ratio38.52P/E Ratio
PEG1223.99PEG
Price to Sales0.66Price to Sales
Price to Book Ratio0.54Price to Book Ratio
Enterprise Value to Revenue0.6
Enterprise Value to EBIT1.93
Enterprise Value to Net Income2
Total Debt to Enterprise0.24
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 26, 2026
EPS Estimate
$0.13
Average shareholder expectation
Revenue Estimate
$1.70 B
Average shareholder expectation

Next Earnings Call

Expected Date
March 23, 2027
EPS Estimate
$0.22
Average shareholder expectation
Revenue Estimate
$2.05 B
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Wuxi Biologics (Cayman) Inc.

CEO: Zhisheng Chen